Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Foods ; 12(24)2023 Dec 06.
Article in English | MEDLINE | ID: mdl-38137200

ABSTRACT

(1) Background: The COVID-19 pandemic brought the key issues of food security, food safety, and food waste into sharp focus. Türkiye is in the enviable position of being among the top ten agricultural economies worldwide, with a wide diversity of food production. This survey was undertaken in order to gain insights into consumer behaviour and attitudes in Türkiye with respect to these issues. The objective was to highlight strengths and weaknesses, identify areas for improvement, and present strategies for the future. (2) Methods: This survey was carried out between April and May 2022 in 12 provinces throughout Türkiye. Face-to-face interviews were performed with 2400 participants representing a cross-section of ages, educational attainment, and socio-economic categories. The findings were evaluated statistically. (3) Results: The results provide an insight into attitudes and behaviours, both pre-COVID-19 and during the pandemic. In several ways, the pandemic enhanced knowledge and improved behaviour, leading to improvements in diet and reductions in food waste. However, worrying concerns about food safety persist. Specific attention has been given to understanding patterns of bread consumption, particularly in consideration of waste. (4) Conclusions: It is hoped that the results of this survey will increase dialogue between the components of the food sector, encourage education initiatives, and contribute to improving food safety and security and reducing food waste in Türkiye and beyond.

2.
Br J Nutr ; 124(4): 374-385, 2020 08 28.
Article in English | MEDLINE | ID: mdl-32279690

ABSTRACT

There is strong evidence that foods containing dietary fibre protect against colorectal cancer, resulting at least in part from its anti-proliferative properties. This study aimed to investigate the effects of supplementation with two non-digestible carbohydrates, resistant starch (RS) and polydextrose (PD), on crypt cell proliferative state (CCPS) in the macroscopically normal rectal mucosa of healthy individuals. We also investigated relationships between expression of regulators of apoptosis and of the cell cycle on markers of CCPS. Seventy-five healthy participants were supplemented with RS and/or PD or placebo for 50 d in a 2 × 2 factorial design in a randomised, double-blind, placebo-controlled trial (the Dietary Intervention, Stem cells and Colorectal Cancer (DISC) Study). CCPS was assessed, and the expression of regulators of the cell cycle and of apoptosis was measured by quantitative PCR in rectal mucosal biopsies. SCFA concentrations were quantified in faecal samples collected pre- and post-intervention. Supplementation with RS increased the total number of mitotic cells within the crypt by 60 % (P = 0·001) compared with placebo. This effect was limited to older participants (aged ≥50 years). No other differences were observed for the treatments with PD or RS as compared with their respective controls. PD did not influence any of the measured variables. RS, however, increased cell proliferation in the crypts of the macroscopically-normal rectum of older adults. Our findings suggest that the effects of RS on CCPS are not only dose, type of RS and health status-specific but are also influenced by age.


Subject(s)
Cell Proliferation/drug effects , Dietary Supplements , Glucans/pharmacology , Intestinal Mucosa/cytology , Rectum/cytology , Starch/pharmacology , Aberrant Crypt Foci/metabolism , Adult , Aged , Aged, 80 and over , Colonic Neoplasms/metabolism , Double-Blind Method , Feces/chemistry , Female , Healthy Volunteers , Humans , Male , Middle Aged
3.
Nutr J ; 14: 23, 2015 Mar 08.
Article in English | MEDLINE | ID: mdl-25889643

ABSTRACT

BACKGROUND: Three independent trials were conducted to evaluate postprandial triglyceride (TG) responses in subjects with different lipid metabolism. The effect of polydextrose (PDX), a soluble non-digestible carbohydrate, on postprandial response was also studied using practically relevant, high fat meal interventions. METHODS: A total of 19 normolipidemic (average BMI 24.1 kg/m(2)), 21 overweight/hyperlipidemic (average BMI 29.6 kg/m(2)) and 18 obese/non-diabetic subjects (average BMI 33.6 kg/m(2)) were included in the study. On two separate occasions all subjects ate two high-fat meals (4293 kJ, 36% from fat), one with PDX (either 12.5 g or 15 g) and one without PDX during placebo-controlled, double-blind, crossover and randomized trials. To obtain the triglyceride measurements venous blood samples were taken before the consumption of the test meal and five times afterwards, up to 6 h post-test meal. The triglyceride responses were modeled using a mixed-effects linear model. RESULTS: The key variables that explain the variation of the postprandial triglyceride response in the different subject groups were: baseline triglyceride concentration, time point, and PDX vs. placebo treatment (p < 0.05). The maximum postprandial TG concentration was more pronounced in hyperlipidemic group compared to normolipidemic (p < 0.001) or obese groups (p < 0.01). The modeled TG response analysis showed that irrespective of the study population PDX supplementation was one of the factors significantly reducing triglyceride response compared to the placebo treatment (p < 0.05). CONCLUSIONS: Subjects with elevated fasting triglyceride levels display exaggerated and prolonged postprandial triglyceride responses. PDX, a soluble non-digestible carbohydrate, may offer a dietary concept for reducing the postprandial triglyceride response after the consumption of a meal containing a high concentration of fat.


Subject(s)
Diet, High-Fat/adverse effects , Glucans/pharmacology , Hyperlipidemias/diet therapy , Lipid Metabolism/drug effects , Obesity/diet therapy , Triglycerides/blood , Adult , Body Mass Index , Cross-Over Studies , Double-Blind Method , Female , Food Additives/administration & dosage , Food Additives/pharmacology , Glucans/administration & dosage , Humans , Hyperlipidemias/blood , Hyperlipidemias/metabolism , Male , Middle Aged , Obesity/blood , Obesity/metabolism , Postprandial Period/drug effects , Treatment Outcome , Young Adult
4.
Br J Nutr ; 105(2): 322-8, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20860884

ABSTRACT

The present report summarises a meeting held by the Food & Health Forum at the Royal Society of Medicine, London, on 27 May 2010. The objective of the meeting was to review the problems associated with the use of evidence-based nutrition and to discuss what constitutes the efficacy for foods and food constituents and how the strength and consistency of the evidence can be assessed and adapted to circumstances in which health claims are to be used on food products. The meeting highlighted the limitations with the present evidence-based nutrition models with the prospect that this may have long-term consequences for nutrition science and ultimately the consumer who may not benefit from new science that could have an impact on health.


Subject(s)
Evidence-Based Practice , Nutritional Sciences , Food Labeling , Food, Organic , Humans , Legislation, Food , London , Nutrition Policy
5.
Biosci Biotechnol Biochem ; 74(10): 2016-21, 2010.
Article in English | MEDLINE | ID: mdl-20944426

ABSTRACT

Polydextrose is a randomly linked complex glucose oligomer that is widely used as a sugar replacer, bulking agent, dietary fiber and prebiotic. Polydextrose is poorly utilized by the host and, during gastrointestinal transit, it is slowly degraded by intestinal microbes, although it is not known which parts of the complex molecule are preferred by the microbes. The microbial degradation of polydextrose was assessed by using a simulated model of colonic fermentation. The degradation products and their glycosidic linkages were measured by combined gas chromatography and mass spectrometry, and compared to those of intact polydextrose. Fermentation resulted in an increase in the relative abundance of non-branched molecules with a concomitant decrease in single-branched glucose molecules and a reduced total number of branching points. A detailed analysis showed a preponderance of 1,6 pyranose linkages. The results of this study demonstrate how intestinal microbes selectively degrade polydextrose, and provide an insight into the preferences of gut microbiota in the presence of different glycosidic linkages.


Subject(s)
Colon/microbiology , Glucans/chemistry , Glucans/metabolism , Glycosides/chemistry , Metagenome , Fermentation , Humans
6.
Biosci Biotechnol Biochem ; 71(8): 1834-43, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17690482

ABSTRACT

Effects of cocoa mass and supplemented dietary fiber (polydextrose) on microbial fermentation were studied by combining digestion simulations of stomach and small intestine with multi-staged colon simulations. During the four phases of digestion, concentrations of available soluble proteins and reducing sugars reflected in vivo absorption of nutrients in small intestine. In colon simulation vessels, addition of polydextrose to digested cocoa mass significantly increased concentrations of total short-chain fatty acids and butyric acid, from 103 to 468 mM (P<0.01) and from 12 to 22 mM (P<0.01), respectively. Long-chain fatty acid concentrations (decreasing from 1,222 to 240 mM) were mainly affected by the presence of digested cocoa mass. Cocoa mass with or without polydextrose addition significantly decreased production of cadaverine (P<0.02) and branched-chain fatty acids compared to control during colon simulations. Results indicate beneficial effects on metabolism of colonic microbiota after digestion of cocoa mass, and even more so with polydextrose addition.


Subject(s)
Cacao/metabolism , Fermentation/drug effects , Gastrointestinal Tract/microbiology , Glucans/pharmacology , Animals , Bacteria/drug effects , Bacteria/metabolism , Cadaverine/analysis , Colon/drug effects , Colon/microbiology , Digestion , Fatty Acids/analysis , Gastrointestinal Tract/drug effects , Glucans/metabolism , Humans , Models, Biological
7.
Appetite ; 49(3): 535-53, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17610996

ABSTRACT

Should future nutritional recommendations for the general population take into account the notion of glycaemic index (GI)? This question is all the more legitimate as the glycaemic response to foods seems to be a factor that affects satiety and could therefore affect food intake. The aim of this review was to evaluate whether altering the glycaemic response per se can modulate satiety and to assess the short-term and long-term consequences. A systematic review of human intervention studies was performed. Confounding factors that may influence both GI and satiety were taken into consideration when selecting the studies. Thirty-two studies were thus selected and analysed. There is evidence from the short-term studies (1 day) that low-glycaemic foods or meals have higher satietogenic effect than high-glycaemic foods or meals. This substantiates claims such as 'low-GI foods help one to feel fuller for longer than equivalent high-GI foods'. The mechanisms involved may be the specific effect of blood glucose levels on satiety (glucostatic theory) and other stimuli (e.g. peptides) involved in the control of appetite. In some studies, however it seems difficult to tease out the separate effect of the lowering of postprandial glycaemia per se and fibres. Because of the increasing number of confounding variables in the available long-term studies, it is not possible to conclude that low-glycaemic diets mediate a health benefit based on body weight regulation. The difficulty of demonstrating the long-term health benefit of a satietogenic food or diet may constitute an obstacle to the recognition of associated claims.


Subject(s)
Body Weight/physiology , Dietary Carbohydrates/pharmacokinetics , Glycemic Index , Satiation/physiology , Blood Glucose/metabolism , Body Weight/drug effects , Dietary Carbohydrates/administration & dosage , Dietary Carbohydrates/classification , Dietary Fiber/metabolism , Dietary Fiber/pharmacology , Energy Intake , Humans , Intestinal Absorption , Nutritive Value , Randomized Controlled Trials as Topic , Satiation/drug effects
8.
Br J Nutr ; 98(1): 123-33, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17391567

ABSTRACT

Dietary fibre has been proposed to decrease risk for colon cancer by altering the composition of intestinal microbes or their activity. In the present study, the changes in intestinal microbiota and its activity, and immunological characteristics, such as cyclo-oxygenase (COX)-2 gene expression in mucosa, in pigs fed with a high-energy-density diet, with and without supplementation of a soluble fibre (polydextrose; PDX) (30 g/d) were assessed in different intestinal compartments. PDX was gradually fermented throughout the intestine, and was still present in the distal colon. Irrespective of the diet throughout the intestine, of the four microbial groups determined by fluorescent in situ hybridisation, lactobacilli were found to be dominating, followed by clostridia and Bacteroides. Bifidobacteria represented a minority of the total intestinal microbiota. The numbers of bacteria increased approximately ten-fold from the distal small intestine to the distal colon. Concomitantly, also concentrations of SCFA and biogenic amines increased in the large intestine. In contrast, concentrations of luminal IgA decreased distally but the expression of mucosal COX-2 had a tendency to increase in the mucosa towards the distal colon. Addition of PDX to the diet significantly changed the fermentation endproducts, especially in the distal colon, whereas effects on bacterial composition were rather minor. There was a reduction in concentrations of SCFA and tryptamine, and an increase in concentrations of spermidine in the colon upon PDX supplementation. Furthermore, PDX tended to decrease the expression of mucosal COX-2, therefore possibly reducing the risk of developing colon cancer-promoting conditions in the distal intestine.


Subject(s)
Dietary Fiber/administration & dosage , Food Additives/administration & dosage , Glucans/administration & dosage , Intestines/microbiology , Animals , Biomarkers/analysis , Cecum/immunology , Cecum/microbiology , Colon/immunology , Colon/microbiology , Cyclooxygenase 1/genetics , Cyclooxygenase 2/genetics , Dietary Fiber/analysis , Dietary Supplements , Energy Intake/immunology , Fatty Acids, Volatile/analysis , Female , Food Additives/analysis , Gene Expression/genetics , Glucans/analysis , Immunoglobulin A/analysis , Intestinal Mucosa/immunology , Intestine, Small/immunology , Intestine, Small/microbiology , Intestines/immunology , Male , Swine
9.
Nutr Cancer ; 52(1): 94-104, 2005.
Article in English | MEDLINE | ID: mdl-16091009

ABSTRACT

A 4-stage colon simulator and a cell culture-based human intestinal epithelial function model were combined to study the effects of a soluble fiber, polydextrose (PDX), on intestinal microbes and mucosal functions relevant to the risk of colon cancer. We observed sustained degradation of PDX throughout the different stages of the model. The fermentation was characterized by gradual degradation of PDX, production of short-chain fatty acids, and no increasing in putrefactive markers. We observed less marked effects in the microbial densities. When we applied colon fermentation metabolites obtained from the simulators with PDX to Caco-2 colon cancer cell line, a significant dose-dependent decreasing effect on cyclooxygenase-2 (COX-2) and an increasing effect on COX-3 expression levels were observed. PDX concentration appeared not to have effect on the expression levels of COX-1. Overexpression of COX-2 and decreased expression of COX-1 have been suggested to be characteristics of colon cancer. The exact physiological role of COX-3, an intron-retaining splice variant of COX-1, is not known, but it is suspected to play a role in transcriptional regulation of COX-1 and COX-2. In vitro modulation of COX expression by colon microbial fermentation products of polydextrose offers an interesting starting point for further studies on possible risk-decreasing effect of PDX on the development of colon cancer.


Subject(s)
Bacteria/metabolism , Colonic Neoplasms/metabolism , Food Additives/pharmacology , Glucans/pharmacology , Intestinal Mucosa/chemistry , Prostaglandin-Endoperoxide Synthases/metabolism , Caco-2 Cells , Colonic Neoplasms/etiology , Cyclooxygenase 1/genetics , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Dose-Response Relationship, Drug , Fermentation , Food Additives/metabolism , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Glucans/metabolism , Humans , Intestinal Mucosa/microbiology , Models, Biological , Prostaglandin-Endoperoxide Synthases/genetics
10.
Appl Environ Microbiol ; 70(8): 4505-11, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15294779

ABSTRACT

In vitro fermentations were carried out by using a model of the human colon to simulate microbial activities of lower gut bacteria. Bacterial populations (and their metabolic products) were evaluated under the effects of various fermentable substrates. Carbohydrates tested were polydextrose, lactitol, and fructo-oligosaccharide (FOS). Bacterial groups of interest were evaluated by fluorescence in situ hybridization as well as by species-specific PCR to determine bifidobacterial species and percent-G+C profiling of the bacterial communities present. Short-chain fatty acids (SCFA) produced during the fermentations were also evaluated. Polydextrose had a stimulatory effect upon colonic bifidobacteria at concentrations of 1 and 2% (using a single and pooled human fecal inoculum, respectively). The bifidogenic effect was sustained throughout all three vessels of the in vitro system (P = 0.01 seen in vessel 3), as corroborated by the bacterial community profile revealed by %G+C analysis. This substrate supported a wide variety of bifidobacteria and was the only substrate where Bifidobacterium infantis was detected. The fermentation of lactitol had a deleterious effect on both bifidobacterial and bacteroides populations (P = 0.01) and decreased total cell numbers. SCFA production was stimulated, however, particularly butyrate (beneficial for host colonocytes). FOS also had a stimulatory effect upon bifidobacterial and lactobacilli populations that used a single inoculum (P = 0.01 for all vessels) as well as a bifidogenic effect in vessels 2 and 3 (P = 0.01) when a pooled inoculum was used. A decrease in bifidobacteria throughout the model was reflected in the percent-G+C profiles.


Subject(s)
Bacteria/isolation & purification , Colon/microbiology , Glucans/metabolism , Oligosaccharides/metabolism , Sugar Alcohols/metabolism , Bacteria/genetics , Bacteria/metabolism , Bifidobacterium , Colon/metabolism , Culture Media , Ecosystem , Fatty Acids, Volatile/metabolism , Fermentation , Humans , In Situ Hybridization, Fluorescence , Polymerase Chain Reaction , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...